Martínez-Martínez M, Mosqueda-Taylor A, Carlos-Bregni R, Ramoa-Pires F, Delgado-Azañero W, Neves-Silva R, Aldape-Barrios B, Paes-de Almeida O. Comparative histological and immunohistochemical study of ameloblastomas and ameloblastic carcinomas. Med Oral Patol Oral Cir Bucal. 2017 May 1;22 (3):e324-32.

doi:10.4317/medoral.21901

http://dx.doi.org/doi:10.4317/medoral.21901

1. Martínez Martínez M, Mosqueda-Taylor A, Carlos R, Delgado-Aza-ero W, de Almeida OP. Malignant odontogenic tumors: a multicentric Latin American study of 25 cases. Oral Dis. 2014;20:380-5. https://doi.org/10.1111/odi.12130

2. Yoon HJ, Hong SP, Lee JI, Lee SS, Hong SD. Ameloblastic carcinoma: an analysis of 6 cases with review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:904-13. https://doi.org/10.1016/j.tripleo.2009.06.045

3. Barnes L, Eveson JW, Reichart PA, et al. World Health Organization Classiﬁcation Of Tumours: Pathology and Genetics of Tumours of the Head and Neck. Lyon: IARC. 2005.

4. Lesot H, Brook AH. Epithelial histogenesis during tooth develop- ment. Arch Oral Biol. 2009;54:S25-33. https://doi.org/10.1016/j.archoralbio.2008.05.019

5. Costa P, Parsons M. New insights into the dynamics of cell adhesions. Int Rev Cell Mol Biol. 2010;283:57-91. https://doi.org/10.1016/S1937-6448(10)83002-3

6. Fregnani ER, da Cruz Perez DE, de Almeida OP, Kowalski LP, Soares FA, de Abreu Alves F. Clinicopathological study and treatment outcomes of 121 cases of ameloblastomas. Int J Oral Maxillofac Surg. 2010;39:145-9. https://doi.org/10.1016/j.ijom.2009.11.022

7. Costa AF, Altemani A, Hermsen M. Current concepts on dedifferentiation/high-grade transformation in salivary gland tumors. Patholog Res Int. 2011;2011:325965. https://doi.org/10.4061/2011/325965

8. do Prado RF, da Silva Machado AL, Colombo CE, Carvalho YR. Immunohistochemical study of the expression of fatty acid synthase and Ki-67 in salivary gland tumors. J Oral Pathol Med. 2011;40:467-75. https://doi.org/10.1111/j.1600-0714.2011.01023.x

9. Al-Salihi KA, Ling Yoke LI, Azlina A. P53 gene mutation and protein expression. in ameloblastomas. Braz J Oral Sci. 2006;17:1034-40.

10. Matsuzaki H, Katase N, Hara M, Asaumi J, Yanagi Y, Unetsubo T, et al. Ameloblastic carcinoma: a case report with radiological features of computed tomography and magnetic resonance imaging and positron emission tomography. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112:e40-7. https://doi.org/10.1016/j.tripleo.2011.01.023

11. Loyola AM, Cardoso SV, de Faria PR, Servato JP, Eisenberg AL, Dias FL, et al. Ameloblastic carcinoma: a Brazilian collaborative study of 17 cases. Histopathology. 2016;69:687-701. https://doi.org/10.1111/his.12995

12. Karakida K, Aoki T, Sakamoto H, Takahashi M, Akamatsu T, Ogura G, et al. Ameloblastic carcinoma, secondary type: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:e33-7. https://doi.org/10.1016/j.tripleo.2010.08.018

13. Nobusawa A, Sano T, Yokoo S, Oyama T. Ameloblastic carcinoma developing in preexisting ameloblastoma with a mutation of the p53 gene: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:e146-50. https://doi.org/10.1016/j.oooo.2014.03.021

14. Abiko Y, Nagayasu H, Takeshima M, Yamazaki M, Nishimura M, Kusano K, et al. Ameloblastic carcinoma ex ameloblastoma: report of a case-possible involvement of CpG island hypermethylation of the p16 gene in malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:72-6. https://doi.org/10.1016/j.tripleo.2006.01.021

15. Crivelini MM, de Araújo VC, de Sousa SO, de Araújo NS. Cytokeratins in epithelia of odontogenic neoplasms. Oral Dis. 2003;9:1-6. https://doi.org/10.1034/j.1601-0825.2003.00861.x

16. Kaminagakura E, Domingos PL, da Rosa MR Loyola AM, Cardoso SV, Lopes MC, et al. Detection of cytokeratins in ghost cells of calcifying cystic odontogenic tumor indicates an altered keratinization and hair follicle differentiation for their development. Ann Diagn Pathol. 2013;17:514-7. https://doi.org/10.1016/j.anndiagpath.2013.07.002

17. Arzi B, Murphy B, Nemec A, Vapniarsky N, Naydan DK, Verstraete FJ. Expression of cytokeratins in the epithelium of canine odontogenic tumours. J Comp Pathol. 2011;145:345-51. https://doi.org/10.1016/j.jcpa.2011.03.003

18. Hunter KD, Speight PM. The diagnostic usefulness of immunohistochemistry for odontogenic lesions. Head Neck Pathol. 2014;8:392-9. https://doi.org/10.1007/s12105-014-0582-0

19. Martínez-Martínez M, Mosqueda-Taylor A, Delgado-Aza-ero W, Rumayor-Pi-a A, de Almeida OP. Primary intraosseous squamous cell carcinoma arising in an odontogenic keratocyst previously treated with marsupialization: case report and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121:87-95. https://doi.org/10.1016/j.oooo.2015.08.015

20. Varun BR, Ranganathan K, Rao UK, Joshua E. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis. J Investig Clin Dent. 2014;5:214-9. https://doi.org/10.1111/jicd.12038

21. Lo Muzio L, Santarelli A, Caltabiano R, Rubini C, Pieramici T, Giannone N, et al. p63 expression correlates with pathological features and biological behaviour of odontogenic tumours. Histopathology. 2006;49:211-4. https://doi.org/10.1111/j.1365-2559.2006.02423.x

22. Takeda T, Sugihara K, Hirayama Y, Hirano M, Tanuma JI, Semba I. Immunohistological evaluation of Ki-67, p63, CK19 and p53 expression in oral epithelial dysplasias. J Oral Pathol Med. 2006;35:369-75. https://doi.org/10.1111/j.1600-0714.2006.00444.x

23. Atarbashi Moghadam S, Atarbashi Moghadam F, Mokhtari S, Eini E. Immunohistochemical analysis of P63 expression in odontogenic lesions. Biomed Res Int. 2013;2013:624176. https://doi.org/10.1155/2013/624176

24. Kumamoto H, Ooya K. Expression of E-cadherin and alpha-catenin in epithelial odontogenic tumors: an immunohistochemical study. J Oral Pathol Med. 1999;28:152-7. https://doi.org/10.1111/j.1600-0714.1999.tb02015.x

25. Alves Pereira KM, do Amaral BA, dos Santos BR, Galvão HC, Freitas Rde A, de Souza LB. Immunohistochemical expression of E-cadherin and beta-catenin in ameloblastomas and tooth germs. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:425-31. https://doi.org/10.1016/j.tripleo.2009.10.032

26. Bologna-Molina R, Mosqueda-Taylor A, Lopez-Corella E, Almeida OP, Carrasco-Daza D, Garcia-Vazquez F, et al. Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas. Oral Oncol. 2008;44:805-11. https://doi.org/10.1016/j.oraloncology.2007.10.007

27. Bologna-Molina R, Mosqueda-Taylor A, Lopez-Corella E, de Almeida OP, Carrasco-Daza D, Farfán-Morales JE, et al. Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma. Pathol Int. 2009;59:229-33. https://doi.org/10.1111/j.1440-1827.2009.02355.x

28. Safadi RA, Quda BF, Hammad HM. Immunohistochemical expression of K6, K8, K16, K17, K19, maspin, syndecan-1 (CD138), α-SMA, and Ki-67 in ameloblastoma and ameloblastic carcinoma: diagnostic and prognostic correlations. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121:402-11. https://doi.org/10.1016/j.oooo.2015.11.015

29. Bologna-Molina R, Mosqueda-Taylor A, de Almeida-Oslei P, Toral-Rizo V, Martínez-Mata G. Peripheral desmoplastic ameloblastoma: histopathological and immunohistochemical profile of a case. Med Oral Patol Oral Cir Bucal. 2010;15:e846-9. https://doi.org/10.4317/medoral.15.e846